1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer : A Sub-Study of RASTEN—A Randomized Trial with Low Molecular Weight Heparin
(
- Contribution to journal › Article
- 2022
-
Mark
Coagulation and other aspects of the cardiovascular system in small cell lung cancer
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)
(
- Contribution to journal › Article
- 2019
-
Mark
Biomarkers of venous thromboembolism in cancer : A silent echo from local events?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)
(
- Contribution to journal › Article
- 2018
-
Mark
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer : The RASTEN trial
(
- Contribution to journal › Article
-
Mark
Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer : A sub-study of RASTEN - A randomized trial with low molecular weight heparin
(
- Contribution to journal › Article